Phenomics Australia

As we approach the #HolidaySeason, we want to thank all our #PhenomicsAustralia users for accessing our services and supporting us throughout the year, without our users we would not be able to continue enabling #precisionmedicince and #impactfulresearch. 😊 🧪 🧫 Best wishes and we look forward to working with you all in 2025. 🧡 #NCRISImpact ➡️ https://lnkd.in/dsEH4QW

Thank you to all the #PhenomicsAustralia staff members for your support throughout the year, enabling impactful research would not possible without our dedicated teams across Australia 👏 🔬 🧬 🩺 Best wishes for a restful break and happy holidays!! 🧡 😊

As the year comes to an end, we would like to thank the Australian Government Department of Education and the NCRIS Health Group for their support, it is a pleasure working together! Best wishes for the holiday season! 👏 😊 Bioplatforms Australia | EMBL | National Imaging Facility Population Health Research Network | Therapeutic Innovation Australia #NCRISImpact

🚨 Exciting opportunity in genomics! The BRF - Biomolecular Resource Facility Genomics team at ANU is looking for a Senior Technical Officer (NGS) to join their team for a two-year term. This position will be responsible for providing broad-ranging NGS services within the long-read sequencing team. Key responsibilities include: 🔬 Library preparation (DNA, RNA, single-cell) and high molecular weight DNA isolation 📊 Sample QC analysis and data evaluation ⚙️ Running sequencing instrumentation (ONT and PacBio) and protocol optimisation If you have a strong molecular biology background, great customer service, and project management expertise, apply before the 26th of January 2025. https://lnkd.in/g7pxTJhw

Calling all genome engineers! 🧬 Australia's premier CRISPR conference is back by popular demand! 🗓️ 27th-28th Feb, 2025 📍 Ian Potter Auditorium, Parkville, VIC Registration and abstract submission for CRISPR Down Under 2025 are OPEN NOW. Tickets are selling fast, so get in while spots last! #CDU2025 🇦🇺🦘 https://crispr.org.au/

We want to introduce you to Dr Andrew Kueh, member of Phenomics Australia’s Scientific Director’s team and Head of the Melbourne Advanced Genome Editing Centre (MAGEC) at Olivia Newton-John Cancer Research Institute Read more: https://lnkd.in/gZtAapJi #NCRISImpact

🏭 The AIBN is home to Australia's biggest network of National Collaborative Research Infrastructure (NCRIS) facilities – and this week we got to show them off to some special guests. Our researchers had the pleasure of hosting members of the Group of Senior Officials (GSO) on Global Research Infrastructures for a tour of the building, providing a look at the extensive range of equipment and capabilities we have under our roof. Along for the tour with our deputy director (research) Professor Kristofer Thurecht was Josephine Church, Dr Carthage Smith, Grace Campbell, and Imraan Patel, who were in town for the GSO’s 16th meeting. Guests were given a look at six of our fantastic NCRIS projects, including facilities supported by the National Imaging Facility, Microscopy Australia, ANFF Queensland, Therapeutic Innovation Australia, Phenomics Australia, and Bioplatforms Australia. 🌍 The GSO on Research Infrastructures is a working group under the G7 that serves the shared policy goals of its member countries in ensuring that world class research infrastructures are available to promote high quality research. Thanks for stopping by!

Pipeline Accelerator 2024-25 (Round 1) successful recipients announced Phenomics Australia in partnership with Therapeutic Innovation Australia (TIA), and the National Deuteration Facility (NDF) (ANSTO), is thrilled to announce the successful recipients of the Pipeline Accelerator 2024-25 (Round 1). ➡️ https://lnkd.in/gjYRye-R Supported through the National Collaborative Research Infrastructure Strategy (NCRIS) program, this initiative helps address the medical products challenge outlined in the 2021 National Research Infrastructure Roadmap. Together, Phenomics Australia, TIA, and NDF provide academic researchers and SMEs access to world-class Australian translational medical research infrastructure, spanning the molecular basis of health and disease to clinical trials. This round, 37 projects will share a total of $1,263,387 in voucher awards with a total cash co-investment fund of $1,316,674, facilitating access to national research infrastructure (NRI) to accelerate therapeutic translation and improve human health. Supported research areas include kidney, heart, cancer, and infectious diseases. These vouchers will subsidise a maximum of $50,000 of the total cost to access these translation NRIs. Eleven recipients were awarded with the Phenomics Australia Pipeline Accelerator 2024-25 (Round 1) and are listed here (https://lnkd.in/gjYRye-R). Among the recipients, we would like to highlight Dr Aude Dorison, PhD’s (Murdoch Children's Research Institute (MCRI))’s project on screening for new treatments for glomerular disease with a new stem cell reporter line. This project is jointly supported by the Induced Pluripotent Stem Cell Derivation & CRISPR Gene Editing Facility (MCRI) (Phenomics Australia) and Drug Discovery Facility (TIA). Notably, several recipients are continuing their journey with us – a testament to its impact and value in advancing therapeutic research. For instance, Dr Denny Cottle from Monash Biomedicine Discovery Institute (Monash University) has previously received support from TIA and in this round is receiving support from Phenomics Australia, highlighting the sustained value of these initiatives. #NCRISImpact Australian Government Department of Education

Earlier this month, Phenomics Australia’s CEO, Prof Michael Dobbie, joined an esteemed panel at the #ICRI2024 symposium, hosted by the #NCRIS Health Group. The panel discussion, titled "Challenges and opportunities for international cooperation of health research infrastructure", brought together experts from around the globe to explore strategies for fostering collaboration across key areas, including phenomics, imaging, therapeutics, and population outcomes. Prof Michael Dobbie shared insights into the vital role of Phenomics Australia in supporting international collaboration advancing health research and the impact of connecting infrastructures across nations, alongside panelists Prof Wojtek James Goscinski, (National Imaging Facility), Dr Michael Raess, (INFRAFRONTIER), Antje Keppler, Euro-BioImaging, ERIC Forum Chaired by: Ian Smith, EMBL Australia, Population Health Research Network Antje Keppler, Euro-BioImaging, ERIC Forum Merran Smith, Population Health Research Network #ICRI2024 #HealthResearch #NCRIS #Collaboration #MedicalInnovation EMBL Australia | Phenomics Australia | Therapeutic Innovation Australia | Bioplatforms Australia | National Imaging Facility | Population Health Research Network Photo credit: National Imaging Facility

Pipeline Accelerator 2024-25 (Round 1) successful recipients announced Phenomics Australia in partnership with Therapeutic Innovation Australia (TIA), and the National Deuteration Facility (NDF) (ANSTO), is thrilled to announce the successful recipients of the Pipeline Accelerator 2024-25 (Round 1). ➡️ https://lnkd.in/gjYRye-R Supported through the National Collaborative Research Infrastructure Strategy (NCRIS) program, this initiative helps address the medical products challenge outlined in the 2021 National Research Infrastructure Roadmap. Together, Phenomics Australia, TIA, and NDF provide academic researchers and SMEs access to world-class Australian translational medical research infrastructure, spanning the molecular basis of health and disease to clinical trials. This round, 37 projects will share a total of $1,263,387 in voucher awards with a total cash co-investment fund of $1,316,674, facilitating access to national research infrastructure (NRI) to accelerate therapeutic translation and improve human health. Supported research areas include kidney, heart, cancer, and infectious diseases. These vouchers will subsidise a maximum of $50,000 of the total cost to access these translation NRIs. Eleven recipients were awarded with the Phenomics Australia Pipeline Accelerator 2024-25 (Round 1) and are listed here (https://lnkd.in/gjYRye-R). Among the recipients, we would like to highlight Dr Aude Dorison, PhD’s (Murdoch Children's Research Institute (MCRI))’s project on screening for new treatments for glomerular disease with a new stem cell reporter line. This project is jointly supported by the Induced Pluripotent Stem Cell Derivation & CRISPR Gene Editing Facility (MCRI) (Phenomics Australia) and Drug Discovery Facility (TIA). Notably, several recipients are continuing their journey with us – a testament to its impact and value in advancing therapeutic research. For instance, Dr Denny Cottle from Monash Biomedicine Discovery Institute (Monash University) has previously received support from TIA and in this round is receiving support from Phenomics Australia, highlighting the sustained value of these initiatives. #NCRISImpact Australian Government Department of Education